Patent details

EP3417708 Title: ADMINISTRATION OF INTRAVENOUS IBUPROFEN

Basic Information

Publication number:
EP3417708
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP181839291
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ADMINISTRATION OF INTRAVENOUS IBUPROFEN
French Title of Invention:
ADMINISTRATION D'IBUPROFÈNE PAR VOIE INTRAVEINEUSE
German Title of Invention:
VERABREICHUNG VON INTRAVENÖSEM IBUPROFEN
SPC Number:

Dates

Filing date:
12/03/2010
Grant date:
17/06/2020
EP Publication Date:
26/12/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/06/2020
EP B1 Publication Date:
17/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/03/2021
Expiration date:
12/03/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/06/2020
 
 

Name:
Cumberland Pharmaceuticals, Inc.
Address:
2525 West End Avenue, Suite 950, Nashville, TN 37203, United States (US)

Inventor

Name:
Pavliv, Leo
Address:
United States (US)

Priority

Priority Number:
159585 P
Priority Date:
12/03/2009
Priority Country:
United States (US)

Classification

IPC classification:
A01N 37/10; A61K 9/00; A61K 9/08; A61K 31/19; A61K 31/192; A61K 31/485; A61P 41/00;

Publication

European Patent Bulletin

Issue number:
202025
Publication date:
17/06/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages